News

Support for people with hemophilia

Leverkusen – In celebration of World Hemophilia Day on April 17, 2008, Bayer HealthCare donated €250,000 and more than 950,000 international units of Kogenate® FS, a recombinant Factor VIII product to treat hemophilia, to the World Federation of Hemophilia (WFH). The donations are evidence of Bayer’s ongoing commitment to the hemophilia community. Over the past four years, the company has donated more than €1 million to the WFH. By holding the annual World Hemophilia Day, the WHF aims to increase awareness of the needs of people around the world living with hemophilia and help improve their care.

These activities for hemophilia patients are another expression of the Bayer Group’s social responsibility. Together with numerous partners, Bayer HealthCare has for many years supported a variety of projects aiming at improving health care worldwide.